No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020
PURPOSE: The first SARS-CoV-2 cases in Europe were reported in January 2020. Recently, concern arose on unrecognized infections before this date. For a better understanding of the pandemic, we retrospectively analyzed patient samples for SARS-CoV-2 from the prospective CAPNETZ study cohort.
METHODS: We used nasopharyngeal swab samples from a cohort of well characterized patients with community acquired pneumonia of the CAPNETZ study group, recruited from different geographic regions across Germany, Austria, the Netherlands, and Switzerland between 02nd December 2019 and 28th April 2020. Multiplex real-time RT-PCR for a broad range of respiratory pathogens and SARS-CoV-2 real-time RT-PCR were performed on all samples.
RESULTS: In our cohort, respiratory pathogens other than SARS-CoV-2 were detected in 21.5% (42/195) of patients with rhinovirus as the most frequently detected pathogen. The detection rate increased to 29.7% (58/195) when SARS-CoV-2 was included. No SARS-CoV-2 positive sample was detected before end of March 2020.
CONCLUSIONS: Respiratory viral pathogens accounted for a considerable number of positive results but no SARS-CoV-2 case was identified before the end of March 2020.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Infection - 48(2020), 6 vom: 03. Dez., Seite 971-974 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Panning, Marcus [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Community acquired pneumonia |
|---|
| Anmerkungen: |
Date Completed 08.12.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s15010-020-01471-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311989969 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311989969 | ||
| 003 | DE-627 | ||
| 005 | 20231225143436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-020-01471-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1039.xml |
| 035 | |a (DE-627)NLM311989969 | ||
| 035 | |a (NLM)32621281 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Panning, Marcus |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.12.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: The first SARS-CoV-2 cases in Europe were reported in January 2020. Recently, concern arose on unrecognized infections before this date. For a better understanding of the pandemic, we retrospectively analyzed patient samples for SARS-CoV-2 from the prospective CAPNETZ study cohort | ||
| 520 | |a METHODS: We used nasopharyngeal swab samples from a cohort of well characterized patients with community acquired pneumonia of the CAPNETZ study group, recruited from different geographic regions across Germany, Austria, the Netherlands, and Switzerland between 02nd December 2019 and 28th April 2020. Multiplex real-time RT-PCR for a broad range of respiratory pathogens and SARS-CoV-2 real-time RT-PCR were performed on all samples | ||
| 520 | |a RESULTS: In our cohort, respiratory pathogens other than SARS-CoV-2 were detected in 21.5% (42/195) of patients with rhinovirus as the most frequently detected pathogen. The detection rate increased to 29.7% (58/195) when SARS-CoV-2 was included. No SARS-CoV-2 positive sample was detected before end of March 2020 | ||
| 520 | |a CONCLUSIONS: Respiratory viral pathogens accounted for a considerable number of positive results but no SARS-CoV-2 case was identified before the end of March 2020 | ||
| 650 | 4 | |a Historical Article | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Community acquired pneumonia | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Multiplex RT-PCR | |
| 650 | 4 | |a Respiratory pathogens | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Wiener, Julius |e verfasserin |4 aut | |
| 700 | 1 | |a Rothe, Kathrin |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Jochen |e verfasserin |4 aut | |
| 700 | 1 | |a Pletz, Mathias W |e verfasserin |4 aut | |
| 700 | 1 | |a Rohde, Gernot |e verfasserin |4 aut | |
| 700 | 1 | |a Rupp, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Witzenrath, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Spinner, Christoph D |e verfasserin |4 aut | |
| 700 | 0 | |a Members of the CAPNETZ study group |e verfasserin |4 aut | |
| 700 | 1 | |a Dreher, M |e investigator |4 oth | |
| 700 | 1 | |a Cornelissen, C |e investigator |4 oth | |
| 700 | 1 | |a Knüppel, W |e investigator |4 oth | |
| 700 | 1 | |a Stolz, D |e investigator |4 oth | |
| 700 | 1 | |a Suttorp, N |e investigator |4 oth | |
| 700 | 1 | |a Bauer, W |e investigator |4 oth | |
| 700 | 1 | |a Mikolajewska, A |e investigator |4 oth | |
| 700 | 1 | |a Witzenrath, M |e investigator |4 oth | |
| 700 | 1 | |a Pankow, W |e investigator |4 oth | |
| 700 | 1 | |a Gläser, S |e investigator |4 oth | |
| 700 | 1 | |a Thiemig, D |e investigator |4 oth | |
| 700 | 1 | |a Prediger, M |e investigator |4 oth | |
| 700 | 1 | |a Schmager, S |e investigator |4 oth | |
| 700 | 1 | |a Kolditz, M |e investigator |4 oth | |
| 700 | 1 | |a Schulte-Hubbert, B |e investigator |4 oth | |
| 700 | 1 | |a Langner, S |e investigator |4 oth | |
| 700 | 1 | |a Rohde, G |e investigator |4 oth | |
| 700 | 1 | |a Bellinghausen, C |e investigator |4 oth | |
| 700 | 1 | |a Panning, M |e investigator |4 oth | |
| 700 | 1 | |a Hoffmann, C |e investigator |4 oth | |
| 700 | 1 | |a Welte, T |e investigator |4 oth | |
| 700 | 1 | |a Freise, J |e investigator |4 oth | |
| 700 | 1 | |a Barten, G |e investigator |4 oth | |
| 700 | 1 | |a Kröner, W |e investigator |4 oth | |
| 700 | 1 | |a Nawrocki, M |e investigator |4 oth | |
| 700 | 1 | |a Naim, J |e investigator |4 oth | |
| 700 | 1 | |a Illig, T |e investigator |4 oth | |
| 700 | 1 | |a Klopp, N |e investigator |4 oth | |
| 700 | 1 | |a Pletz, M |e investigator |4 oth | |
| 700 | 1 | |a Kroegel, C |e investigator |4 oth | |
| 700 | 1 | |a Schleenvoigt, B |e investigator |4 oth | |
| 700 | 1 | |a Forstner, C |e investigator |4 oth | |
| 700 | 1 | |a Moeser, A |e investigator |4 oth | |
| 700 | 1 | |a Drömann, D |e investigator |4 oth | |
| 700 | 1 | |a Parschke, P |e investigator |4 oth | |
| 700 | 1 | |a Franzen, K |e investigator |4 oth | |
| 700 | 1 | |a Rupp, J |e investigator |4 oth | |
| 700 | 1 | |a Käding, N |e investigator |4 oth | |
| 700 | 1 | |a Wouters, M |e investigator |4 oth | |
| 700 | 1 | |a Walraven, K |e investigator |4 oth | |
| 700 | 1 | |a Braeken, D |e investigator |4 oth | |
| 700 | 1 | |a Spinner, C |e investigator |4 oth | |
| 700 | 1 | |a Zaruchas, A |e investigator |4 oth | |
| 700 | 1 | |a Schaberg |e investigator |4 oth | |
| 700 | 1 | |a Heigener, D |e investigator |4 oth | |
| 700 | 1 | |a Hering, I |e investigator |4 oth | |
| 700 | 1 | |a Albrich, W |e investigator |4 oth | |
| 700 | 1 | |a Waldeck, F |e investigator |4 oth | |
| 700 | 1 | |a Rassouli, F |e investigator |4 oth | |
| 700 | 1 | |a Baldesberger, S |e investigator |4 oth | |
| 700 | 1 | |a Stenger, S |e investigator |4 oth | |
| 700 | 1 | |a Wallner, M |e investigator |4 oth | |
| 700 | 1 | |a Burgmann, H |e investigator |4 oth | |
| 700 | 1 | |a Traby, L |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d 1973 |g 48(2020), 6 vom: 03. Dez., Seite 971-974 |w (DE-627)NLM00001740X |x 1439-0973 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2020 |g number:6 |g day:03 |g month:12 |g pages:971-974 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15010-020-01471-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2020 |e 6 |b 03 |c 12 |h 971-974 | ||